CHKA and cancer: Our work further suggest that in part by restoring DAB2IP expression to suppress cancer cell growth, proliferation and metastasis, Akt inhibitors or Fbw7/CKI inhibitors may be beneficial in treating various types of human cancers, particularly the metastatic cancers that are associated with poor survival rates.